
Sign up to save your podcasts
Or
At the 2019 European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain, Dr. Matt Birnholz got a chance to talk with Dr. Hans Petter Eikesdal about the head-turning study on PARP inhibitors he presented at the conference.
4.4
1414 ratings
At the 2019 European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain, Dr. Matt Birnholz got a chance to talk with Dr. Hans Petter Eikesdal about the head-turning study on PARP inhibitors he presented at the conference.
90,949 Listeners
60 Listeners
1 Listeners
3 Listeners
3 Listeners
0 Listeners
6 Listeners
18 Listeners
0 Listeners
707 Listeners
253 Listeners
3,336 Listeners
56,231 Listeners
433 Listeners
1,092 Listeners
6,070 Listeners
32 Listeners
40 Listeners
492 Listeners